Biostar Pharmaceuticals is a holding company. Through its wholly-owned subsidiary, Shaanxi Biostar Biotech, Ltd. and its variable interest entities Shaanxi Aoxing Pharmaceutical Co., Ltd. and Shaanxi Weinan Huaren Pharmaceuticals Ltd., Co. develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in China. Co.'s primary product is the XinAoxing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. As of Dec 31 2016, Co. manufactured and sold 12 OTC medications and 17 prescription-based pharmaceuticals which were sold and distributed in over 25 provinces and provincial-level cities throughout China. We show 9 historical shares outstanding datapoints in our coverage of BSPM's shares outstanding history.
Understanding the changing numbers of BSPM shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like BSPM versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching BSPM by allowing them to research BSPM shares outstanding history
as well as any other stock in our coverage universe. |
Free BSPM Email Alerts:
Video: Shares Outstanding Importance
